SCHEMBL9305601

SCHEMBL9305601

CCCC(O)(C(=O)O)[C@H](N)[12C](=O)O

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.40
MAPT P10636 1/20 0.40
PTGS1 P23219 1/20 0.40
HSPD1 P10809 1/20 0.39
BLM P54132 1/20 0.39
HSPE1 P61604 1/20 0.39
CPT2 P23786 1/20 0.36
ACLY P53396 1/20 0.36
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
HPGD P15428 1/20 0.35
RECQL P46063 1/20 0.35
HSD17B10 Q99714 1/20 0.35
SLC1A2 P43004 5/20 0.34
SLC1A1 P43005 5/20 0.34
SLC1A3 P43003 4/20 0.34
GRIK1 P39086 2/20 0.34
GRIK2 Q13002 2/20 0.34
CHRM1 P11229 1/20 0.33
AKR1A1 P14550 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28219381 0.77 ACLY (0.57) HSPD1BLMHSPE1CPT2ACLY
SCHEMBL14920851 0.76 HSPD1 (0.38) ALDH1A1HSPD1BLMHSPE1CPT2
SCHEMBL7050626 0.74 CPT2 (0.39) ALDH1A1HSPD1BLMHSPE1CPT2
SCHEMBL9358019 0.74 ALDH1A1 (0.48) ALDH1A1MAPTPTGS1HSD17B10SLC1A2
SCHEMBL6270504 0.74 ACLY (0.59) ALDH1A1MAPTPTGS1HSPD1BLM
SCHEMBL5969708 0.73 ALDH1A1 (0.48) ALDH1A1MAPTPTGS1HSPD1BLM
SCHEMBL6262487 0.72 PTGS1 (0.52) ALDH1A1MAPTPTGS1HSD17B10SLC1A2
SCHEMBL28261059 0.71 CPT2 (0.40) ALDH1A1MAPTPTGS1HSPD1BLM
SCHEMBL24015558 0.71 ALDH1A1 (0.45) ALDH1A1MAPTPTGS1MEN1KMT2A
SCHEMBL6262500 0.71 PTGS1 (0.56) ALDH1A1MAPTPTGS1HSD17B10SLC1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0495265-B1 Acid-labile linker molecules AKZO NOBEL NV (NL) 1994-08-03 EP disclosed
US-5306809-A Cancer immune therapy AKZO N.V. (NL) 1994-04-26 US disclosed
EP-0495265-A1 Acid-labile linker molecules Akzo Nobel N.V. (NL) 1992-07-22 EP disclosed